| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |